- Home
- SGBX vs PHIO Comparison
SGBX vs PHIO Comparison
Compare SGBX & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- PHIO
- Stock Information
- Founded
- SGBX 2007
- PHIO 2011
- Country
- SGBX United States
- PHIO United States
- Employees
- SGBX N/A
- PHIO N/A
- Industry
- SGBX RETAIL: Building Materials
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- PHIO Health Care
- Exchange
- SGBX Nasdaq
- PHIO Nasdaq
- Market Cap
- SGBX 2.1M
- PHIO 2.3M
- IPO Year
- SGBX 2017
- PHIO N/A
- Fundamental
- Price
- SGBX $0.52
- PHIO $2.47
- Analyst Decision
- SGBX
- PHIO Strong Buy
- Analyst Count
- SGBX 0
- PHIO 1
- Target Price
- SGBX N/A
- PHIO $36.00
- AVG Volume (30 Days)
- SGBX 2.7M
- PHIO 52.4K
- Earning Date
- SGBX 12-03-2024
- PHIO 11-14-2024
- Dividend Yield
- SGBX N/A
- PHIO N/A
- EPS Growth
- SGBX N/A
- PHIO N/A
- EPS
- SGBX N/A
- PHIO N/A
- Revenue
- SGBX $8,193,436.00
- PHIO N/A
- Revenue This Year
- SGBX $273.79
- PHIO N/A
- Revenue Next Year
- SGBX $39.31
- PHIO N/A
- P/E Ratio
- SGBX N/A
- PHIO N/A
- Revenue Growth
- SGBX N/A
- PHIO N/A
- 52 Week Low
- SGBX $0.49
- PHIO $2.17
- 52 Week High
- SGBX $15.38
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- SGBX 29.03
- PHIO 42.71
- Support Level
- SGBX $0.49
- PHIO $2.17
- Resistance Level
- SGBX $0.71
- PHIO $2.66
- Average True Range (ATR)
- SGBX 0.14
- PHIO 0.30
- MACD
- SGBX -0.02
- PHIO -0.03
- Stochastic Oscillator
- SGBX 2.53
- PHIO 19.71
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.